chr7-144110334-T-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001005480.2(OR2A2):c.752T>A(p.Phe251Tyr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000161 in 1,613,954 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001005480.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
OR2A2 | NM_001005480.2 | c.752T>A | p.Phe251Tyr | missense_variant | 1/1 | ENST00000408979.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
OR2A2 | ENST00000408979.3 | c.752T>A | p.Phe251Tyr | missense_variant | 1/1 | NM_001005480.2 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152162Hom.: 1 Cov.: 32
GnomAD3 exomes AF: 0.0000361 AC: 9AN: 249142Hom.: 0 AF XY: 0.0000296 AC XY: 4AN XY: 135146
GnomAD4 exome AF: 0.0000150 AC: 22AN: 1461792Hom.: 0 Cov.: 33 AF XY: 0.0000165 AC XY: 12AN XY: 727212
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152162Hom.: 1 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74336
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 25, 2022 | The c.752T>A (p.F251Y) alteration is located in exon 1 (coding exon 1) of the OR2A2 gene. This alteration results from a T to A substitution at nucleotide position 752, causing the phenylalanine (F) at amino acid position 251 to be replaced by a tyrosine (Y). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at